文章摘要
39例新型冠状病毒肺炎患者临床特征分析
Clinical features of 39 cases with COVID-19
  
DOI:10.3969/j.issn.1007-8134.2020.04.005
中文关键词: 新型冠状病毒肺炎  流行病学  临床特征  临床转归
英文关键词: COVID-19  epidemiology  clinical characteristic  clinical outcome
基金项目:
作者单位
黄慧琴 郴州市第二人民医院感染科 
谷 斌 郴州市第二人民医院感染科 
曹晓英 郴州市第二人民医院感染科 
罗小巍 郴州市第二人民医院感染科 
蒋太敏 郴州市第二人民医院感染科 
陈检才 郴州市第二人民医院感染科 
关艳丽 郴州市第二人民医院感染科 
张 彦 郴州市第二人民医院感染科 
黄 华 郴州市第二人民医院感染科 
摘要点击次数: 579
全文下载次数: 526
中文摘要:
      目的 分析新型冠状病毒肺炎(coronavirus disease-2019, COVID-19)患者的流行病学特点、临床表现、实验室检查、影像学特征及临床转归等资料,为COVID-19的诊治提供参考。方法 纳入2020年1月21日—2月24日在郴州市第二人民医院经SARS-CoV-2核酸检测阳性的COVID-19患者39例,对其流行病学特征、首发症状、WBC、淋巴细胞计数、降钙素原(procalcitonin, PCT)、IL-6、CRP、CD4+ T淋巴细胞计数、CD8+ T淋巴细胞计数、影像学及临床转归等资料进行分析。结果 39例患者中,2例为轻型,35例为普通型,2例为重型,除去无明确接触史及返乡前就已发病的患者,其余潜伏期为2.0~12.0 d,平均为(7.7±3.3)d,其中32例(82.05%)发病前有武汉旅居史或武汉返乡人员密切接触史,5例(12.82%)发病前有广东旅居史或广东返乡人员密切接触史,2 例(5.12%)无明确可疑接触史;有7起家族聚集性病例,共26例,占发病总例数的66.67%。24例(61.54%)患者早期症状为发热,25例(64.10%)患者早期症状为咳嗽,有少数患者存在咽痛、肌肉酸痛、纳差、咳嗽、腹泻,3例(7.69%)无任何临床表现。WBC下降12 例(30.77%);淋巴细胞计数下降8例(20.51%);T淋巴细胞计数下降3例(7.69%);ALT升高12例(30.77%);TBIL升高10例(25.64%);LDH升高21例(53.85%);CRP升高18例(46.15%);IL-6升高3例(7.69%);患者 降钙素原均正常。肺部CT病灶呈双肺多发,以外侧带胸膜下为主,多表现为斑片状、云絮状磨玻璃样改变。6例普通型COVID-19患者出院后随访,肺部病灶完全吸收,吸收时间18.0~31.0 d,平均(26.8±4.5) d。结论 本研究前期纳入的COVID-19患者为输入性病例,后期则以家庭聚集性病例为主;临床表现以发热和咳嗽为常见症状,少数患者症状轻甚至无症状;大部分患者为普通型;胸部CT表现多为斑片状、云絮状磨玻璃样改变;肺部病灶的好转不与核酸转阴完全同步;目前随访的普通型COVID-19患者预后良好。
英文摘要:
      Objective To analyze the epidemiological characteristics, clinical manifestations, laboratory tests, imaging features and clinical outcomes of patients with novel coronavirus disease-2019 (COVID-19), and provide reference for the diagnosis and treatment of COVID-19. Methods Thirty-nine COVID-19 patients with positive results in SARS-CoV-2 nucleic acid test were enrolled from the Second People’s Hospital of Chenzhou City from January 21, 2020 to February 24, 2020. Their epidemiological characteristics, initial symptoms, WBC, lymphocyte count, procalcitonin (PCT), IL-6, CRP, CD4+ T lymphocyte count, CD8+ T lymphocyte count, imaging data and clinical outcome were analyzed. Results Among the 39 patients, there were 2 mild cases, 35 common cases and 2 severe cases. With the exception of those patients with no definite contact history or having the onset prior to their return, the incubation period was 2.0-12.0 days with a mean of (7.7 ± 3.3) days, 32 cases (82.05%) had a history of sojourn or contact in Wuhan before the onset of the disease, 5 cases (12.82%) had a history of sojourn or contact in Guangdong before the onset of the disease, and 2 cases (5.12%) had no clear suspected contact history. There were 7 familial aggregation, 26 patients in total, accounting for 66.67% of the total patients. Twenty-four patients (61.54%) had fever in the early stage, 25 patients (64.10%) had cough in the early stage, a few patients had pharyngeal pain, muscle soreness, anorexia, cough and diarrhea, and 3 patients (7.69%) had no clinical manifestations. WBC decreased in 12 cases (30.77%). Lymphocyte count decreased in 8 cases (20.51%). T cell count decreased in 3 cases (7.69%). ALT increased in 12 cases (30.77%). TBIL increased in 10 cases (25.64%). LDH increased in 21 cases (53.85%); CRP elevated in 18 cases (46.15%); IL-6 elevated in 3 cases (7.69%); and all patients had normal PCT. CT findings of the lung showed multiple lesions in both lungs, mainly in the lateral subpleural zone, with patchy and cloud flocculent ground glass changes. Six patients with common COVID-19 were followed up after discharge. The lung lesions were completely absorbed for 18.0-31.0 days, with an average of (26.8±4.5) days. Conclusions In this study, COVID-19 patients in the early stage are imported cases, those in the advanced stage are family clustering cases. Fever and cough are common symptoms in the clinical manifestations. A few patients are mild or even asymptomatic. Most of the patients are common cases. Patchy, cloud flocculent ground glass changes are predominant by chest CT findings. The improvement of lung lesions is not completely synchronized with the negative transformation of nucleic acid. At present, the prognosis of common COVID-19 patients is good during follow-ups.
HTML   查看全文   下载PDF阅读器
关闭